FSSNX | SASVX | FSSNX / SASVX | |
Total Expense Ratio | 0.03 | 1.44 | 2% |
Annual Report Gross Expense Ratio | 0.03 | 1.44 | 2% |
Fund Existence | 14 years | 22 years | - |
Gain YTD | 1.626 | -2.541 | -64% |
Front Load | N/A | 6% | - |
Min. Initial Investment | 0 | 2500 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 25.6B | 96.6M | 26,501% |
Annual Yield % from dividends | 0.92 | 0.96 | 96% |
Returns for 1 year | 12.15 | -7.10 | -171% |
Returns for 3 years | 36.67 | -11.78 | -311% |
Returns for 5 years | 64.11 | -3.27 | -1,958% |
Returns for 10 years | 77.87 | -52.88 | -147% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
CADPX | 21.74 | 0.13 | +0.60% |
Columbia International Div Inc Inst2 | |||
IBNYX | 24.97 | 0.13 | +0.52% |
Macquarie Balanced Fund Class Y | |||
WAMFX | 23.72 | 0.11 | +0.47% |
Boston Trust Walden Midcap | |||
GPGEX | 8.68 | 0.04 | +0.46% |
Grandeur Peak Global Explorer Instl | |||
SHSAX | 61.93 | 0.10 | +0.16% |
BlackRock Health Sciences Opps Inv A |